Data as of Mar 07
| -1.19 / -8.85%|
The 5 analysts offering 12-month price forecasts for Tetraphase Pharmaceuticals Inc have a median target of 16.00, with a high estimate of 25.00 and a low estimate of 15.00. The median estimate represents a +30.51% increase from the last price of 12.26.
The current consensus among 5 polled investment analysts is to Buy stock in Tetraphase Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.